 |
Previous Article | Next Article 
Volume 16, Number 16,
Issue of August 15, 1996
pp. 4846-4860
Copyright ©1996 Society for Neuroscience
Voltage-Gated K+ Channel Subunits: Expression and
Distribution of Kv 1 and Kv 2 in Adult Rat Brain
Kenneth J. Rhodes1,
Michael M. Monaghan1,
Nestor X. Barrezueta1,
Stanley Nawoschik1,
Zewditu Bekele-Arcuri2,
Maria F. Matos2,
Kensuke Nakahira2,
Lee E. Schechter1, and
James S. Trimmer2
1 CNS Disorders, Wyeth-Ayerst Research, Princeton, New
Jersey 08543, and 2 Department of Biochemistry and Cell
Biology and Institute for Cell and Developmental Biology, State
University of New York, Stony Brook, New York 11794
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
Recent cloning of K+ channel subunits
revealed that these cytoplasmic polypeptides can dramatically alter the
kinetics of current inactivation and promote efficient glycosylation
and surface expression of the channel-forming subunits. Here, we
examined the expression, distribution, and association of two of these
subunits, Kv 1 and Kv 2, in adult rat brain. In situ
hybridization using cRNA probes revealed that these -subunit genes
are heterogeneously expressed, with high densities of Kv 1 mRNA in
the striatum, CA1 subfield of the hippocampus, and cerebellar Purkinje
cells, and high densities of Kv 2 mRNA in the cerebral cortex,
cerebellum, and brainstem. Immunohistochemical staining using
subunit-specific monoclonal and affinity-purified polyclonal antibodies
revealed that the Kv 1 and Kv 2 polypeptides frequently co-localize
and are concentrated in neuronal perikarya, dendrites, and terminal
fields, and in the juxtaparanodal region of myelinated axons.
Immunoblot and reciprocal co-immunoprecipitation analyses indicated
that Kv 2 is the major subunit present in rat brain membranes,
and that most K+ channel complexes containing
Kv 1 also contain Kv 2. Taken together, these data suggest
that Kv 2 is a component of almost all K+
channel complexes containing Kv1 subunits, and that individual
channels may contain two or more biochemically and functionally
distinct -subunit polypeptides.
Key words:
ion channel;
central nervous system;
auxiliary subunit;
striatum;
immunoprecipitation;
immunohistochemistry
INTRODUCTION
Voltage-gated K+ channels
are composed of pore-forming subunits and associated cytoplasmic
-subunit polypeptides (Pongs, 1995 ). These channels are critical for
action potential conduction and neurotransmitter release, and are
essential to the control of neuronal excitability (Hille, 1992 ).
Expression of -subunit mRNAs in heterologous cells gives rise to
tetrameric channel complexes with electrophysiological characteristics
similar to A-type or delayed-rectifier channels (for review, see Pongs,
1992 ). The large number of -subunit genes, their ability to assemble
into heteromultimers (Ruppersberg et al., 1990 ; Sheng et al., 1993 ;
Wang et al., 1993 ; Scott et al., 1994a ; Rhodes et al., 1995 ), and their
heterogeneous expression in mammalian brain undoubtedly contributes to
the diversity of voltage-gated K+ channels
in situ (Stühmer et al., 1989 ; Jan and Jan, 1990 ).
However, the recent discovery of auxiliary subunits associated with ion
channels in general (for review, see Isom et al., 1994 ), and with
voltage-gated K+ channels in particular (Parcej
et al., 1992 ; Rettig et al., 1994 ; Scott et al., 1994b ), revealed that
their electrophysiological and biochemical properties can be
dramatically affected by the presence of subunits (Rettig et al.,
1994 ; Majumder et al., 1995 ; Morales et al., 1995 ; Shi et al., 1996 ).
This association of subunits with K+ channels
not only increases the potential for diversity, it also indicates that
the functional properties of individual channels are governed by the
specific combination of and subunits present in the channel
complex.
The subunits of voltage-gated K+ channels
were identified as 38-41 kDa polypeptides associated with the
dendrotoxin acceptor purified from bovine brain (Parcej and Dolly,
1989 , 1992; Scott et al., 1994a ,b), and as a 38 kDa polypeptide in
immunoprecipitated rat brain K+ channel complexes
(Trimmer, 1991 ). Subsequent cloning of cDNAs encoding a bovine subunit (Scott et al., 1994b ); the related Kv 1, Kv 2, and Kv 3
in rat brain (Rettig et al., 1994 ; Heinemann et al., 1995 ); and closely
related subunits in Drosophila (Chouinard et al., 1995 ),
ferret (Morales et al., 1995 ), and human tissues (England et al.,
1995a ,b; Majumder et al., 1995 ; McCormack et al., 1995 ) indicated that
these subunits are highly conserved and that some can modulate the
rate of inactivation of certain subunits (Rettig et al., 1994 ;
England et al., 1995a ,b; Heinemann et al., 1995 ; Majumder et al., 1995 ;
McCormack et al., 1995 ; Morales et al., 1995 ).
We recently reported that Kv 1 and Kv 2 associate with subunits
early in their biosynthesis and exert chaperone-like effects on the subunits, promoting their efficient glycosylation and stable expression
in the plasma membrane (Shi et al., 1996 ). In addition, we reported
that Kv 1 and Kv 2 associate with all members of the
Shaker-related (Kv1) -subunit subfamily upon
co-expression in transfected mammalian cells (Nakahira et al., 1996 ).
Here, we used riboprobes and antibodies specific for Kv 1 and Kv 2
to examine their expression, subcellular distribution, and
co-association in adult rat brain. We observed that these subunits
are widely expressed, and that immunoreactivity for Kv 1 and Kv 2
is concentrated in multiple subcellular domains including neuronal
somata and dendrites, the paranodal segments of myelinated axons, and
in the terminal fields of several cortical and subcortical projection
systems. We also observed that Kv 2 is the predominant -subunit
isoform in rat brain; although Kv 1 mRNA is widely expressed, the
Kv 1 polypeptide is not a major component of the total rat brain
-subunit pool, and almost all of the Kv 1 that is present is in
K+ channel complexes that also contain Kv 2.
Together, these observations suggest that subunits are integral
components of K+ channel complexes, and that the
inclusion of Kv 1 in Kv 2-containing complexes may serve to fine
tune the electrophysiological properties of channels in specific brain
regions.
MATERIALS AND METHODS
Materials. All reagents were molecular biology grade
from Sigma (St. Louis, MO) or Boehringer Mannheim (Indianapolis, IN),
except where otherwise noted.
Preparation of 35S-labeled cRNA probes. DNA
templates for riboprobe synthesis were prepared by the PCR using
plasmid clones containing the full-length rat Kv 1 or Kv 2 cDNAs
(Nakahira et al., 1996 ) or a partial Kv 2 cDNA (K. Nakahira, S. Nawoschik, J. Trimmer, unpublished observations) as PCR templates. Two
independent riboprobes targeted to unique, nonoverlapping regions of
Kv 1 or Kv 2 were used in the present study. The probe sequences
were checked versus the Genbank database to ensure that they only
recognize the appropriate targets among all deposited sequences. To
generate riboprobes for the Kv 1 subunit, one pair of oligonucleotide
primers was designed to amplify a 264 bp region spanning nucleotides
46 to 218 of the rat Kv 1 cDNA and, in addition, to add the
promoter sequences for T3 RNA polymerase. These primers contained
the following sequences: 5 -CGGATCCG- CTGTGCTGTGGGGTTCTGAGAGGAC-3
(forward); 5 -AATTAACC- CTCACTAAAGGGATATTTCATGCCAGTCTGCT-3
(reverse). The forward primer for this Kv 1 probe contained eight
nucleotides of vector sequence at the 5 end from the BamHI
site used for cloning. A second pair of oligonucleotide primers was
designed to amplify a 271 bp sequence spanning nucleotides 321 to
51 of the rat Kv 1 cDNA and, in addition, to add the promoter
sequences for T3 RNA polymerase. These primers had the following
sequences: 5 -CCTGACCACATGGATCTGGC-3 (forward);
5 -AATTAACCCTCACTAAAGGGCGGCAGAGGGTGAGACGTT-3
(reverse). To generate riboprobes for the Kv 2 subunit, one pair of
primers was designed to amplify a 228 bp fragment from the 3
untranslated region (nucleotides 1130-1357) of the rat Kv 2 cDNA
and, in addition, to add the promoter sequences for T3 RNA polymerase.
These primers had the following sequences:
5 -CCCAGCTCGGACAGTTCCTGGTTCC-3 (forward);
5 -AATTAACCCTCACTAAAGGGGCATCCAGCGAGG AAG- CGGC-3 (reverse). A
second riboprobe for Kv 2 was generated using oligonucleotide primers
designed to amplify a 300 bp fragment spanning nucleotides 809-1108 of
the rat Kv 2 cDNA and, in addition, to add the promoter sequences for
T3 RNA polymerase. These primers contained the following sequences:
5 -ACCAGTGGTTGAAGGACAAG-3 (forward);
5 -AATTAACCCTCACTAAAGGGTGACTTAGGATCTATAGTCC-3 (re-verse). All
PCR products were gel purified on 1.5% low-melt agarose gels, and
bands containing the Kv 1 or Kv 2 products were excised, phenol and
phenol-chloroform extracted, and ethanol precipitated. The pellet then
was dried and resuspended in 1× TE buffer containing (in
mM): 10 Tris/HCl, 1 EDTA, pH 7.4. Fifty nanograms
of DNA template were used for transcription reactions using
35S-CTP (New England Nuclear, Boston, MA) and the
Riboprobe Gemini System (Promega, Madison, WI). Probes were examined by
Northern analysis of rat brain RNA and by Southern analysis of plasmids
containing the Kv 1 and Kv 2 cDNAs. Each probe reacted with a
single band of appropriate size on Northern blots and with only the
appropriate cDNA on the plasmid Southern blots, indicating that these
riboprobes specifically recognized Kv 1 and Kv 2 transcripts (data
not shown).
In situ hybridization. Eight adult male Sprague-Dawley rats
were used for analysis of Kv 1 and Kv 2 mRNA expression by in
situ hybridization histochemistry. Animals were killed by
asphyxiation with CO2, and the brains were
removed, immediately frozen in a bed of pulverized dry ice, and stored
at 70°C. Sections were cut at 10 µm on a Hacker-Brights cryostat
and thaw mounted onto chilled ( 20°C) slides coated with Vectabond
reagent (Vector Labs, Burlingame, CA). All solutions were prepared in
dH2O treated with 0.1% (v/v)
diethylpyrocarbonate and autoclaved. Sections were fixed by immersion
in 4% paraformaldehyde in PBS, pH 7.4, then immersed sequentially in
2× SSC (1× SSC is 0.150 M sodium chloride,
0.015 M sodium citrate),
dH2O, and 0.1 M
triethanolamine, pH 8.0. The sections then were acetylated by immersion
in 0.1 M triethanolamine containing 0.25% (v/v)
acetic anhydride; washed in 0.2× SSC; dehydrated in 50, 70, and 90%
ethanol; and rapidly dried. One ml of prehybridization solution
containing 0.9 M NaCl, 1 mM
EDTA, 5× Denhardt's solution, 0.25 mg/ml single-stranded herring
sperm DNA (Gibco, Gaithersburg, MD), and 50% deionized formamide (EM
Sciences, Gibbstown, NJ) in 10 mM Tris, pH 7.6, was pipetted onto each slide, and the slides incubated for 3 hr at
50°C in a humidified box. The sections then were dehydrated by
immersion in 50, 70, and 90% ethanol and air dried.
Labeled riboprobes were denatured in a small volume (100 µl) of
hybridization solution containing 0.9 M NaCl, 1 mM EDTA, 1× Denhardt's solution, 0.1 mg/ml
yeast tRNA, 0.1 mg/ml single-stranded salmon sperm DNA, dextran sulfate
(10%), 0.08% BSA, 10 mM DTT (Boehringer
Mannheim, Indianapolis, IN), and 50% deionized formamide in 10 mM Tris, pH 7.6, at 95°C (1 min); placed on ice
(5 min); and added at a final concentration of 50,000 cpm/µl to 10 ml
of prewarmed (to 55°C) hybridization solution. The hybridization
solution then was pipetted onto the sections and allowed to hybridize
overnight at 55°C in a humidified chamber. The sections were
subsequently washed once for 45 min at 37°C in 2× SSC containing 10 mM DTT, once for 30 min at 37°C in 1× SSC
containing 50% formamide, and once for 30 min at 37°C in 2× SSC.
Single-stranded and nonspecifically hybridized riboprobe was digested
by immersion in 10 mM Tris, pH 8.0, containing
bovine pancreas RNase A (Boehringer Mannheim) (40 µg/ml), 0.5 M NaCl, and 1 mM EDTA. The
sections then were washed in 2× SSC for 1 hr at 60°C, followed by
0.1× SSC containing 0.5% (w/v) sodium thiosulfate for 2 hr at 60°C.
The sections then were dehydrated in 50, 70, and 90% ethanol
containing 0.3 M ammonium acetate, and dried.
The slides then were loaded into X-ray cassettes and exposed to
Hyperfilm -Max (Amersham, Arlington Heights, IL) for 3-7 d. Once a
satisfactory exposure was obtained, the slides were coated with
nuclear-track emulsion (NTB-2) (Eastman Kodak, Rochester, NY) and
exposed for 7-21 d at 4°C. The emulsion autoradiograms were
developed and fixed according to the manufacturer's instructions, and
the underlying tissue sections were stained with hematoxylin.
To assess nonspecific labeling in the in situ hybridization
procedure, a control probe was generated from a template provided in
the Riboprobe Gemini System kit (Promega catalog #P2651). This vector
was linearized using ScaI, and transcribed using T3 RNA
polymerase. The resulting transcription reaction generates two
products, a 250 bp and a 1525 bp riboprobe, containing only vector
sequence. This control probe mixture was labeled as described above and
added to the hybridization solution at a final concentration of 50,000 cpm/µl. No specific hybridization was observed in control sections;
i.e., these sections gave a very weak uniform hybridization signal that
did not follow neuroanatomical landmarks (data not shown).
Production of synthetic peptides and antibodies. Synthetic
peptides corresponding to amino acids 7-28 from the N terminus of the
rat Kv 1 polypeptide (CTEHNLKSRNGEDRLLSKQSST) (Rettig et al., 1994 )
and amino acids 1-17 of the rat Kv 2 polypeptide
(MYPESTTGSPARLSLRQC) (Rettig et al., 1994 ) were synthesized (Quality
Controlled Biochemicals, Hopkinton, MA) and conjugated to keyhole
limpet hemocyanin (KLH) (1 mg peptide/mg carrier protein) using
sulfo-m-maleimidobenzoyl-N-hydroxysuccinimide
ester (Pierce, Rockford, IL). These peptide/KLH conjugates were
injected into rabbits for the production of polyclonal antisera (Pocono
Rabbit Farm, Canadensis, PA), and into mice for the production of
monoclonal antibodies (mAbs). Production of mAbs and purification of
monoclonal immunoglobulins were performed essentially as described
previously (Trimmer et al., 1985 ), and will be described in detail
elsewhere (Z. Bekele-Arcuri, M. Matos, J. Trimmer, unpublished
observations). For affinity purification of the polyclonal antibodies,
the Kv 1 and Kv 2 peptides were conjugated to SulfoLink coupling
gel (Pierce) via the terminal cysteine residues. Polyclonal
antibodies were affinity purified from immune serum by standard
procedures (Harlow and Lane, 1988 ).
Immunofluorescence. Immunofluorescence staining of
transiently transfected cells expressing Kv 1 and Kv 2 was
performed essentially as described previously (Shi et al., 1994 ).
Briefly, green monkey fibroblast COS-1 cells were cultured on glass
coverslips that had been previously coated with 25 µg/ml
poly-L-lysine. For staining, cells were washed
three times in ice-cold PBS, then fixed and permeabilized by treatment
for 20 min at 4°C with a freshly prepared ice-cold fixative
containing 3% paraformaldehyde/0.1% Triton X-100 in PBS. Cells then
were washed three times in TBS containing 0.1% Triton X-100 (TBS-T),
and nonspecific protein binding sites were blocked by incubation in
TBS-T containing 4.5% w/v nonfat dry milk powder (Blotto-T) (Johnson
et al., 1984 ). Cells then were incubated in primary antibodies diluted
in Blotto-T for 1 hr at room temperature, washed three times in
Blotto-T for 30 min total, and incubated in the appropriate secondary
antibodies for 30 min. After three washes in TBS-T for 15 min total,
cells were mounted in PBS medium containing 90% glycerol and 1 mg/ml
p-phenylenediamine and viewed on a Zeiss Axiophot microscope
using epifluorescence illumination.
Brain membrane preparations. A crude synaptosomal membrane
fraction was prepared from freshly dissected adult rat brains,
essentially as described previously (Trimmer, 1991 , 1993). Briefly,
brains were homogenized in 0.3 M sucrose, 10 mM sodium phosphate, pH 7.4, and 10 mM sodium fluoride, containing a protease
inhibitor cocktail (1 mM phenylmethyl sulfonyl
fluoride, 1 µg/ml leupeptin, 2 µg/ml aprotinin, and 1 µg/ml
pepstatin). The resultant homogenate was centrifuged at 3,000 × g for 10 min to remove nuclei and cellular debris. The
supernatant then was centrifuged at 45,000 × g for 60 min to pellet the membranes. Aliquots of the membrane preparations were
suspended in the homogenization buffer, and protein was determined
using the BCA method (Pierce).
SDS/polyacrylamide gels and immunoblotting. For immunoblots,
50 µg of membrane protein was added to SDS sample buffer, boiled, and
fractionated on 7.5 or 12% SDS/polyacrylamide gels (Maizel, 1971 ).
Disulfide bonds were reduced by the addition of 20 mM 2-mercaptoethanol to the sample buffer. Lauryl
sulfate (Sigma) was the SDS source used for all SDS-PAGE (Shi et al.,
1994 ). After electrophoretic transfer to nitrocellulose paper, the
resulting blots were blocked in TBS containing 4% low fat milk
(Blotto) (Johnson et al., 1984 ), incubated in affinity-purified
antibody diluted 1:50-1:100 in Blotto for 1 hr or undiluted mAb tissue
culture supernatants, and washed three times in Blotto for 30 min
total. Blots then were incubated in HRP-conjugated secondary antibody
(1:2000 dilution in Blotto) (Cappel, West Chester, PA) for 1 hr and
then washed in TBS three times for 30 min total. The blots then were
incubated in substrate for enhanced chemiluminescence (ECL) (Amersham,
Arlington Heights, IL) for 1 min and autoradiographed on preflashed (to
OD545 = 0.15) Kodak X-OMAT LS film.
Immunoprecipitation. Immunoprecipitation reactions were
performed using detergent lysates of rat brain membranes. All
procedures were performed at 4°C. Membranes (1 mg membrane
protein/tube) were solubilized to 1 ml final volume/tube in lysis
buffer (1% Triton X-100, 0.15 M NaCl, 1 mM EDTA, 10 mM sodium
azide, 10 mM Tris/HCl, pH 8.0, containing a
protease inhibitor cocktail (see above). Affinity-purified antibodies
were added and the samples incubated for 2 hr on a rotator, followed by
addition of 20 µl of a 50% suspension of protein A sepharose and
additional incubation for 45 min. After incubation, protein A sepharose
was centrifuged at 10,000 × g for 20 sec, and the
resulting pellets were washed by resuspension and centrifugation six
times with lysis buffer. The final pellets were resuspended in 50 µl
reducing sample buffer, and 20 µl electrophoresed on 12% SDS-PAGE
and subjected to immunoblotting as described above.
Immunohistochemistry. Twelve adult male Sprague-Dawley rats
were deeply anesthetized with sodium pentobarbital (60 mg/kg, i.p.) and
perfused through the ascending aorta with 150 ml of 0.9% saline,
followed by 500 ml of fixative containing freshly prepared 4%
paraformaldehyde in 0.1 M
NaPO4 buffer, pH 7.4 (PB). The brains were
removed, cryoprotected for 18-48 hr in 20% sucrose in PB, frozen in a
bed of pulverized dry ice, and then cut into 35-µm-thick sections on
a sliding microtome. Consecutive 1-in-10 series of sections were
collected in 0.05 M PB and processed for light
microscopic immunohistochemistry as described previously (Rhodes et
al., 1995 ). Affinity-purified rabbit polyclonal anti-Kv 1 and rabbit
anti-Kv 2 antibodies were used at dilutions of 1:1500 and 1:4000,
respectively. Mouse mAbs (purified IgG fractions and tissue culture
supernatants) raised against Kv 1 (clone K9/40) and Kv 2 (clone
K17/70) were used at dilutions of 1:100-1:1500. To verify the
specificity of the immunohistochemical reactions, some sections were
processed either without addition of the primary antibody or using
antibodies incubated previously (1 hr) in vehicle containing an excess
of the synthetic peptide/BSA antigen (5-25 µg/ml). No specific
staining was observed in these control sections (data not shown).
Analysis of sections processed for in situ hybridization and
immunohistochemistry was performed using a Zeiss Axiophot
photomicroscope. Low-magnification photographs of immunohistochemically
stained sections and autoradiograms generated on film were taken using
a Nikon Multiphot macrophotography system.
RESULTS
Localization of Kv 1 and Kv 2 mRNA
General features
Analysis of autoradiograms prepared on film indicated that the
Kv 1 and Kv 2 mRNAs are widely and heterogeneously expressed in
adult rat brain (Table 1). The pair of
riboprobes for Kv 1 generated patterns of hybridization signal that
were indistinguishable from one another, as did the pair of riboprobes
for Kv 2. Taken together with the result of Northern and Southern
blotting using these probes, this result strongly suggests that the
riboprobes used in the present study specifically reveal the presence
of Kv 1 or Kv 2 mRNA.
A very high density of Kv 1 expression was observed in the striatum,
nucleus accumbens, olfactory tubercle, CA1 subfield of the hippocampus,
and entorhinal and posterior cingulate cortices, and in several
midbrain and brainstem motor nuclei (Fig. 1).
Intermediate levels of Kv 1 expression were observed in the piriform
cortex; neocortex; medial septal-diagonal band complex; anterior,
mediodorsal, and ventral tier thalamic nuclei; and the cerebellar
cortex and deep nuclei. Intermediate levels of Kv 1 expression also
were observed in the laterodorsal, ventral posteromedial (VPM), ventral
posterolateral (VPL), and dorsal lateral geniculate, and medial
geniculate nuclei of the thalamus. Low levels of Kv 1 expression were
observed in the globus pallidus and hypothalamus. The highest levels of
Kv 2 expression were observed in the piriform cortex, hippocampal
formation, and in layer II of the entorhinal cortex, with somewhat
lower levels in the neocortex, medial septal-diagonal band complex,
and the anterior, VPM, and VPL nuclei of the thalamus. Low and levels
of Kv 2 expression were observed in the remaining thalamic nuclei and
in the striatum, globus pallidus, and hypothalamus.
Fig. 1.
Expression of Kv 1 and Kv 2 mRNA in adult rat
brain. Horizontal and coronal sections of rat brain were processed by
in situ hybridization histochemistry to localize Kv 1
(A, B, E-G) and Kv 2
(C, D, H-J) mRNA.
Areas containing a high density of hybridization signal appear dark in
these bright-field images. The autoradiograms in
A-D were exposed for 3 d, whereas those in
E-J were exposed for 7 d. At the shorter
exposure time, subtle differences in expression levels are more easily
discernible. For example, there is a comparatively greater density of
Kv 1 mRNA in the CA1 subfield of the hippocampus as compared with the
adjacent CA3 subfield (B). CA1, Hippocampal
subfield; CB, cerebellum; CPu, caudate putamen;
EC, entorhinal cortex; RN, red nucleus;
ms, medial septal nuclei; AN, anterior thalamic
nucleus; MD, mediodorsal thalamic nucleus.
[View Larger Version of this Image (143K GIF file)]
Neocortex and hippocampus
Examination of high-resolution emulsion autoradiograms of sections
processed to visualize hybridization to Kv 1 and Kv 2 mRNAs
indicated that these two transcripts are expressed within cellular
profiles with the size and morphology of neurons as opposed to glial
cells (Fig. 2). Kv 1 mRNA was expressed in large
pyramidal cells in the deep half of layer III and in layers V and VI.
Very high levels of Kv 1 mRNA were observed in small to medium
interneurons in cortical layers II, III, V, and VI. Interestingly, high
levels of Kv 1 mRNA also were observed in small cells juxtaposed to
the subcortical white matter (Fig. 1). In virtually all regions of the
neocortex, Kv 2 mRNA was highly expressed in pyramidal cells in
layers II, III, V, and VI. In proisocortical areas such as the
entorhinal and cingulate cortices, Kv 1 and Kv 2 mRNA also were
highly expressed in large multipolar neurons in layer II (Fig. 2).
Fig. 2.
Cellular localization of Kv 1 and Kv 2 mRNA
expression. Emulsion autoradiograms were prepared to localize Kv 1
and Kv 2 mRNA within individual cells. Cells containing a high
density of mRNA contain a correspondingly high density of silver
grains, which appear as bright spots in these dark-field
images. In posterior cingulate cortex (area 23), Kv 1 mRNA
(A) is highly expressed in many small cells in layers II and
III and larger cells in layer V (arrows), whereas Kv 2
(B) is expressed predominantly in small cells in layer II
and larger cells in layer V (arrows). In the entorhinal
cortex, Kv 1 mRNA (C) is expressed in large and small
cells in layers II, III, V, and VI, whereas Kv 2 mRNA (D)
is expressed at high density in layer II cells and with a lower density
in cells in the remaining layers of this structure. In the caudate
nucleus, there is a very high level of Kv 1 expression (E)
and a lower level of Kv 2 expression (F) in
virtually all cells (arrows). The bundles of myelinated
axons that course through this structure do not contain hybridization
signal (arrowheads). In the basal forebrain, Kv 1
(G) and Kv 2 (H) mRNAs are expressed in
large cells (arrows) with the distribution and frequency
characteristic of the large cholinergic neurons present in this region.
The short arrows in G and H mark the
midline of the brain.
[View Larger Version of this Image (213K GIF file)]
In the hippocampus, Kv 1 mRNA was expressed in dentate granule cells
and in pyramidal cells of all subfields. However, pyramidal cells in
the CA1 subfield expressed higher levels of Kv 1 mRNA than the
adjacent CA2 subfield and subiculum (Fig. 1). In addition, Kv 1 was
expressed in large interneurons located in stratum oriens and radiatum
of all subfields. The distribution of Kv 2 mRNA was strikingly
similar to that observed for Kv 1, with the exception that there
appeared to be a uniformly high density of Kv 2 expression across all
subfields, and Kv 2 mRNA did not appear to be expressed at an
appreciably greater density in hippocampal interneurons.
Striatum and basal forebrain
The greatest density of Kv 1 expression was observed in the
caudate putamen, nucleus accumbens, and olfactory tubercle. Virtually
all neurons in these structures expressed extremely high levels of
Kv 1 mRNA (Figs. 1, 2E). Kv 1 mRNA also was highly
expressed in the medial septal nuclei and the vertical and horizontal
limbs of the diagonal band of Broca in a distribution that closely
resembled the distribution of cholinergic neurons in these structures
(Fig. 2G) (Mesulam et al., 1983 ). In contrast to Kv 1,
there was a low level of Kv 2 expression in the caudate putamen,
nucleus accumbens, and olfactory tubercle (Figs. 1, 2F).
However, there was a high level of Kv 2 expression in the medial
septal and diagonal band nuclei in a pattern that overlapped
with, but was somewhat more extensive than, that observed for Kv 1
(Figs. 1, 2H).
Thalamus and hypothalamus
A moderate density of Kv 1 expression was observed throughout
the thalamus, with a somewhat greater density in the anterior,
mediodorsal, and entopeduncular nuclei (Fig. 1), and a moderate density
in the laterodorsal, VPM, and VPL nuclei. A low level of Kv 1
expression was observed in the hypothalamus, but with a somewhat more
intense hybridization signal in the ventromedial hypothalamic nucleus.
A low to moderate level of Kv 2 expression was observed throughout
the thalamus, with a somewhat greater density in the anterior,
mediodorsal, paracentral, and ventroposterior nuclei. Low levels of
Kv 2 expression also were observed in the hypothalamus, however, as
for Kv 1, there was a somewhat greater density of Kv 2 expression
in the ventromedial nucleus.
Midbrain
Several midbrain motor nuclei, including the red nucleus and
all cranial nerve nuclei, contained a very high density of Kv 1 and
Kv 2 expression (Fig. 1). In addition, cells in the superficial and
deep layers of the superior and inferior colliculi, the periaqueductal
gray, and the pars compacta and pars reticulata of the substantia nigra
expressed intermediate levels of Kv 1 mRNA. Similarly, large neurons
in the deep layers of the superior and inferior colliculi expressed
moderate levels of Kv 2 mRNA, and cells scattered throughout the
substantia nigra pars compacta and pars reticulata expressed moderate
to low levels of Kv 2 mRNA (Fig. 1).
Cerebellum and brainstem
In the cerebellar cortex, Purkinje cells and granule cells
displayed high and moderate levels of Kv 1 expression, respectively,
and small neurons scattered throughout the molecular layer expressed
much lower levels of Kv 1 mRNA. In contrast, Purkinje cells and
granule cells displayed intermediate levels of Kv 2 expression, and
small neurons with a size and distribution similar to basket cells
expressed moderate levels of Kv 2 mRNA. Large neurons in all deep
cerebellar nuclei expressed moderate levels of Kv 1 and Kv 2 mRNA
(Fig. 1).
In the pons and medulla, all cranial nerve sensory and motor nuclei
displayed moderate to high levels of Kv 1 and Kv 2 expression. In
addition, mRNA for both subunits was highly expressed in large
pontine and medullary reticular neurons and in neurons of the superior
and inferior olivary complexes.
Generation and characterization of Kv 1- and Kv 2-specific
polyclonal and mAbs
A polyclonal antiserum was produced by the immunization of rabbits
with a synthetic Kv 1 peptide immunogen, corresponding to N-terminal
amino acids 7-28 of the deduced rat brain Kv 1 sequence (Rettig et
al., 1994 ). This sequence is not present in the deduced sequence of the
rat brain Kv 2 subunit, although some overlap is seen to a
recently identified rat brain Kv 3 subunit (11/22 positions
identical with changes spread throughout the sequences) (Heinemann et
al., 1995 ; Pongs, 1995 ). Thus, it is likely that antibodies generated
to this peptide are specific for Kv 1. Rabbit polyclonal antibodies
raised against this peptide exhibited a high titer against the peptide
on ELISA assays and displayed a monospecific reaction on immunoblot
assays versus rat brain membranes to a 44 kDa polypeptide (Fig.
3). That this peptide was Kv 1 was supported by
analysis of Kv 1 and Kv 2 expressed in COS-1 cells, which showed
that the expressed recombinant Kv 1 polypeptide shared
immunoreactivity and electrophoretic mobility with the putative rat
brain Kv 1 polypeptide (Fig. 3). No corresponding immunoreactivity
was seen to the recombinant 38 kDa Kv 2 polypeptide expressed in
COS-1 cells or present in the crude rat brain membranes on the same
immunoblot (Fig. 3). Immunofluorescence staining of transfected COS-1
cells revealed a similar pattern of immunoreactivity in that the
anti-Kv 1 antibody exhibited a strong immunofluorescence staining of
Kv 1- , but not Kv 2- , transfected cells (Fig.
4).
Fig. 3.
Immunoblot analyses of the Kv 1 and Kv 2
-subunit polypeptides in rat brain membranes and in transfected
COS-1 cells. Crude rat brain membranes (RBM) (50 µg) and
the detergent extracts of COS-1 cells transfected with Kv 1/RBG4
(Kv 1), Kv 2/RBG4 (Kv 2), or RBG4 alone
(vector) were fractionated on a 12.5% SDS gel and
transferred to nitrocellulose, and the resultant immunoblot probed with
either rabbit anti-Kv 1 polyclonal antibody at 1:50 (left)
or mouse anti-Kv 2 mAb K17/70 tissue culture supernatant neat
(right). Signals were visualized using ECL (left,
30 min; right, 1 min). Numbers on left
refer to mobility of prestained molecular weight standards.
[View Larger Version of this Image (47K GIF file)]
Fig. 4.
Analysis of antibody specificity.
Immunofluorescence staining of Kv 1 and Kv 2 subunits expressed
in COS-1 cells. COS-1 cells were transfected with Kv 1/RBG4
(A-D) or Kv 2/RBG4
(E-H) cDNAs. Transfected cells then were
fixed, permeabilized, and incubated with rabbit anti-Kv 1 polyclonal
antibody at 1:100 (A, E), rabbit anti-Kv 2
polyclonal antibody at 1:200 (B, F), mouse
anti-Kv 1 mAb K9/40 at 1:2 (C, G), or
mouse anti-Kv 2 mAb K17/70 at 1:2 (D,
H). Cells then were incubated with Texas Red-conjugated
anti-rabbit (A, B, E,
F) or anti-mouse (C, D,
G, H) secondary antibody.
[View Larger Version of this Image (72K GIF file)]
mAbs generated against the same Kv 1-specific peptide exhibited
similar properties. All of the mAbs exhibited strong reactions in ELISA
assays against the Kv 1 peptide immunogen and in immunofluorescence
staining of COS-1 cells expressing recombinant Kv 1 polypeptide (Fig.
4). Staining was not observed in nontransfected or Kv 2-transfected
cells (Fig. 4). Immunoblot analysis of crude rat brain membranes
revealed that none of the mAbs isolated recognized the SDS-denatured
rat brain Kv 1 polypeptide, although specific immunoreactivity was
seen to the recombinant Kv 1 (but not Kv 2) polypeptide present in
COS-1 cell extracts, perhaps because of the higher expression levels of
Kv 1 in these extracts compared with that observed in rat brain
membranes (data not shown). All of these mAbs, and the rabbit
polyclonal antibody, selectively immunoprecipitate the recombinant
Kv 1 polypeptide present in 35S-methionine
labeled COS-1 cell extracts (data not shown). Additional details on the
generation and characterization of these mAbs will be described
elsewhere.
A polyclonal antiserum was produced by the immunization of rabbits with
a synthetic Kv 2 peptide immunogen, corresponding to N-terminal amino
acids 1-17 of the deduced rat brain Kv 2 sequence (Rettig et al.,
1994 ). This sequence is not present in the deduced sequence of the rat
brain Kv 1 or Kv 3 subunit (Heinemann et al., 1995 ; Pongs,
1995 ). Thus, it is likely that antibodies generated to this peptide
would be specific for Kv 2. Rabbit polyclonal antibodies raised
against this peptide exhibited a high titer against the Kv 2 peptide
on ELISA assays and displayed a monospecific reaction on immunoblot
assays versus rat brain membranes to a 38 kDa polypeptide (Fig. 3).
Additional immunoreactivity was exhibited to a minor, 41 kDa
polypeptide (Fig. 3) that is also recognized by the pan- -subunit
antibody (Rhodes et al., 1995 ). The molecular identity of this 41 kDa
polypeptide is not known; however, the fact that it exhibits
immunoreactivity to both the N-terminally directed anti-Kv 2 antibody
and the C-terminally directed pan- antibody indicates that it is
either a post-translational variant of Kv 2 or an alternative splice
variant of the Kv 2 gene. That the 38 kDa polypeptide was Kv 2 was
supported by analysis of Kv 1 and Kv 2 expressed in COS-1 cells,
which showed that the expressed recombinant Kv 2 polypeptide shared
immunoreactivity and electrophoretic mobility
(Mr = 38 kDa) with the putative rat brain
Kv 2 polypeptide (the 41 kDa variant was not detected). No
corresponding immunoreactivity was seen to the recombinant 44 kDa
Kv 1 polypeptide expressed in COS-1 cells or present in the crude rat
brain membranes on the same immunoblot (Fig. 3). Immunofluorescence
staining of transfected COS-1 cells revealed a similar pattern of
immunoreactivity in that the anti-Kv 2 antibody exhibited a strong
immunofluorescence staining of Kv 2- but not Kv 1- transfected
cells (Fig. 4).
Anti-Kv 2 mAbs were generated against a
glutathione-S-transferase fusion protein containing the
entire Kv 2 polypeptide. All of the N-terminally directed mAbs
exhibited monospecific immunofluorescence staining of COS-1 cells
expressing recombinant Kv 2, but not Kv 1, polypeptide (Fig. 4). No
staining to untransfected cells was seen (Fig. 4). Immunoblot analysis
of crude rat brain membranes revealed that only the K17/70 mAb
recognizes the SDS-denatured rat brain Kv 2 polypeptide and
recombinant Kv 2 (but not Kv 1) polypeptide present in COS-1 cell
extracts (Fig. 3). Additional details on the generation and
characterization of these mAbs will be described elsewhere.
Reciprocal co-immunoprecipitations: subunit association
To determine whether Kv 1 and Kv 2 were present in the same
rat brain K+ channel complexes, we performed
reciprocal co-immunoprecipitation experiments with the anti-Kv 1 and
anti-Kv 2 antibodies. Detergent lysates were prepared from rat brain
membranes under conditions shown previously to preserve - or
-subunit interactions (Sheng et al., 1993 ; Wang et al., 1993 ; Rhodes
et al., 1995 ; Nakahira et al., 1996 ; Shi et al., 1996 ). These lysates
then were used in immunoprecipitation reactions performed with the
anti-Kv 1 and anti-Kv 2 polyclonal antibodies and with a pan-
polyclonal antibody that recognizes both Kv 1 and Kv 2 (Rhodes et
al., 1995 ). Immunoprecipitations also were performed using a polyclonal
antibody against the Kv2.1 subunit, which should not
co-immunoprecipitate either of these subunits (Rhodes et al.,
1995 ). Immunoprecipitation reactions then were subjected to immunoblot
analyses to assay for the presence of Kv 1 with the anti-Kv 1
polyclonal antibody, for Kv 2 with the K17/70 mAb, and for the
-subunit-associated subunit Kv1.2 with the Kv1.2C polyclonal
antibody (Rhodes et al., 1995 ).
As expected, the anti-Kv 1 antibody immunoprecipitated the 44 kDa
Kv 1 polypeptide from these rat brain extracts (Fig.
5), as did the anti-pan- polyclonal antibody, whereas
the anti-Kv2.1 antibody did not immunoprecipitate detectable amounts of
Kv 1. That the same amount of rabbit IgG was precipitated in each of
these reactions is demonstrated by the ~50 kDa band present in each
immunoprecipitation lane that is attributable to immunoreactivity of
the rabbit IgG from the immunoprecipitating antibody, with the
anti-rabbit secondary antibody used to develop the immunoblots.
Surprisingly, levels of Kv 1 comparable to those observed in the
anti-Kv 1 reaction were co-immunoprecipitated by the anti-Kv 2
polyclonal antibody. Because these immunoprecipitation reactions were
performed under conditions in which antigen is limiting, these data
demonstrate that a large proportion of the Kv 1 found in rat brain is
present in complexes that also contain the Kv 2 subunit (Fig.
5).
Fig. 5.
Presence of Kv 1 and Kv 2 in rat brain
K+ channel complexes. Samples of adult rat brain
membranes (RBM) (60 µg) and aliquots of products of
immunoprecipitation reactions from detergent extracts of 500 µg RBM
with polyclonal antibodies specific for both Kv 1 and Kv 2
(pan- , 1:100), Kv 1 (anti-Kv 1,
1:200), Kv 2 (anti-Kv 2, 1:500), or the Kv2.1 subunit (anti-Kv2.1, 1:200) were size fractionated by 12.5%
SDS-PAGE. Samples were transferred to nitrocellulose and probed with
rabbit anti-Kv 1 polyclonal antibody at 1:50 (left
panel), mouse anti-Kv 2 mAb K17/70 neat (middle
panel), or rabbit anti-Kv1.2 polyclonal antibody at 1:100
(right panel). Bound antibody detected by
ECL-autoradiography for 40 min (left panel) or 3 min
(middle and right panels). Arrows
point to mobility of the heavy-chain polypeptides of the rabbit
immunoglobulins used in the immunoprecipitation reactions and of the
respective K+ channel polypeptides;
numbers at left of the panels denote
Mr of prestained molecular weight
standards. Bands at ~50 kDa (left and right
panels) are heavy chains of rabbit IgG used for
immunoprecipitations, which react with anti-rabbit, but not anti-mouse,
secondary antibody.
[View Larger Version of this Image (29K GIF file)]
These same immunoprecipitation reactions then were assayed for the
presence of Kv 2; because these immunoblots were performed with the
anti-Kv 2 mouse mAb K17/70, the rabbit IgG bands typically seen in
the immunoprecipitation reactions are not visualized. The rabbit
anti-Kv 2 polyclonal antibody was able to immunoprecipitate the 38 kDa Kv 2 polypeptide present in these samples. Comparable amounts of
Kv 2 also were observed in the immunoprecipitation reaction performed
with the anti-pan- polyclonal antibody (Fig. 5). Low levels of
Kv 2 also were observed in the reactions performed with the
anti-Kv 1 antibody, confirming the observation above and indicating
that individual K+ channel complexes may contain
both of these -subunit polypeptides. As expected, the anti-Kv2.1
antibody also was unable to co-immunoprecipitate detectable amounts of
Kv 2. All of the immunoprecipitation reactions performed with the
anti- -subunit antibodies contained Kv1.2 (Fig. 5), showing that each
of these antibodies could effectively recognize and isolate intact
K+ channel complexes.
Immunohistochemical localization of Kv 1 and Kv 2
Analysis of immunohistochemically stained sections indicated that
Kv 1 and Kv 2 are present in cell bodies, dendrites, the
juxtaparanodal regions of myelinated axons, and terminal fields of
several major projection systems. The pattern of immunohistochemical
staining observed with mAbs and polyclonal antibodies to the same subunit was indistinguishable. The areal and laminar distribution of
labeled cells suggests and comparisons of sections processed by
in situ hybridization and immunohistochemistry suggest that
cells expressing Kv 1 and Kv 2 mRNA also are immunoreactive for the
corresponding proteins. Regions containing moderate to intense
immunoreactivity for Kv 1 and Kv 2 were the neocortex, hippocampus,
piriform cortex, striatum, thalamus, cerebellum, cranial nerve nuclei,
and virtually all major white matter pathways. Although it is beyond
the scope of this paper to provide a comprehensive account of
-subunit immunoreactivity in every brain region, the salient
features of the immunohistochemical staining are described below and
summarized in Table 1.
Neocortex and hippocampus
In the neocortex, immunoreactivity for Kv 1 was concentrated
within pyramidal cells and was particularly intense in smaller bipolar
and multipolar interneurons in layers II, III, V, and VI (Fig.
6A). In each of these cell populations,
immunoreactivity for Kv 1 was concentrated within the cell body and
proximal portions of the dendritic tree. Immunoreactivity for Kv 2
also was observed in cortical pyramidal cells, with very intense
labeling of large pyramidal cells in layer V (Fig. 6C).
However, in contrast to immunoreactivity for Kv 1, immunoreactivity
for Kv 2 was concentrated throughout the entire apical dendrite of
layer V pyramidal cells, including fine branches and apical tufts.
Interestingly, the small interneurons that displayed strong
immunoreactivity for Kv 1 were not intensely immunoreactive for
Kv 2. In addition to the somatodendritic staining described above, in
many cortical regions, moderate to intense immunoreactivity for Kv 1
and Kv 2 was observed in axonal profiles coursing throughout the
cortical neuropil and in a pattern consistent with labeling of terminal
fields. This pattern of labeling was particularly intense in the
piriform, posterior cingulate, retrosplenial, and entorhinal cortices.
Myelinated axons in the subcortical white matter as well as other
regions also contained immunoreactivity for Kv 1 and Kv 2. The
staining in these fibers was discontinuous, with a greater density of
reaction product in the juxtaparanodal segments at nodes of Ranvier
(Shi et al., 1996 ).
Fig. 6.
Immunohistochemical localization of Kv 1 and
Kv 2 in the cerebral cortex and striatum. In parietal cortex,
immunoreactivity for Kv 1 (K9/40 mAb) (A) is concentrated
in large pyramidal cells in layer V and in small interneurons
(arrows) concentrated primarily in layers II and III.
Immunoreactivity for Kv 2 (affinity-purified polyclonal antibody)
(C) is concentrated in the somas and apical dendrites of
layer V pyramidal cells. The small interneurons that contain a high
density of immunoreactivity for Kv 1 contain a much lower density of
immunoreactivity for Kv 2. In the striatum, there is a very high
density of immunoreactivity for Kv 1 (B) and Kv 2
(D) in the globus pallidus (GP) and a lower
density in the caudate nucleus (CD). In the globus pallidus,
immunoreactivity for Kv 1 and Kv 2 is primarily concentrated in
terminal fields and is present in both the supra- and subcommissural
segments. AC, Anterior commissure.
[View Larger Version of this Image (159K GIF file)]
In the hippocampal formation, there was a heterogeneous
distribution of Kv 1 and Kv 2 immunoreactivity with moderate to
intense staining of granule and pyramidal cell somata (data not shown).
Immunoreactivity for Kv 1 and Kv 2 also was concentrated within
interneurons in stratum oriens and stratum radiatum of the CA1-CA3
subfields. In the dentate gyrus, granule cells contained a moderate
density of Kv 1 and Kv 2 immunoreactivity. In these cells, staining
was concentrated in the cell soma and did not extend into dendritic
branches, suggesting that this staining is associated with subunits
synthesized within these cells. In the molecular layer of the dentate
gyrus, there was a distinct band of Kv 1 and Kv 2 immunoreactivity
in the middle third and somewhat less intense labeling in the outer
third. As described previously (Rhodes et al., 1995 ), the location of
this band of intense immunoreactivity corresponds closely to the
termination zone of the medial perforant path. In the CA subfields and
subiculum, immunoreactivity for Kv 1 and Kv 2 was distributed
diffusely throughout the neuropil, with a greater density in stratum
radiatum and stratum oriens than in stratum moleculare, and
immunoreactivity for Kv 2, but not Kv 1, was concentrated
throughout the apical dendrites and apical dendritic tufts of
hippocampal pyramidal cells. In the CA3 subfield, there was a moderate
density of Kv 1 immunoreactivity in the mossy fiber zone.
Striatum and basal forebrain
In the caudate nucleus and nucleus accumbens, there was a moderate
density of immunoreactivity for Kv 1 and Kv 2 within neurons of all
sizes and morphologies and distributed diffusely throughout the
neuropil. Interestingly, there was a higher density of immunoreactivity
for Kv 1 and Kv 2 in bundles of axons coursing through the
ventromedial portion of the caudate nucleus than in similar fiber
bundles in the dorsolateral component of this structure. These fibers
appeared to originate from cells within the caudate nucleus and could
be followed in consecutive sections to their apparent termination
throughout the supra- and subcommissural segments of the globus
pallidus (Fig. 6B,D). Additional fibers showing
intense immunoreactivity for Kv 1 and Kv 2 appeared to continue
beyond the globus pallidus and run through the medial forebrain bundle
and cerebral peduncle to terminate within the substantia nigra pars
reticulata (Fig. 7A,C). Intense
terminal-field labeling for Kv 1 and Kv 2 also was observed in the
nucleus accumbens and olfactory tubercle, and in the deep half of the
molecular layer of pyriform cortex.
Fig. 7.
Immunohistochemical localization of Kv 1 and
Kv 2 in the midbrain and cerebellum. In the midbrain,
immunoreactivity for Kv 1 (K9/40 mAb) (A) and Kv 2
(affinity-purified polyclonal antibody) (C) is concentrated
in terminal fields in the pars reticulata of the substantia nigra
(SNr) and in large neurons in the red nucleus
(RN). In the cerebellar cortex, immunoreactivity
for Kv 1 (B) and Kv 2 (D) is concentrated in
the cell bodies of Purkinje cells (P) and in terminal fields
throughout the molecular layer. Immunoreactivity for Kv 2 also is
concentrated in the dendrites of Purkinje cells and in the axon
terminals of basket cells, which form a characteristic synaptic plexus
(arrows) that terminates on the initial segment of Purkinje
cell axons.
[View Larger Version of this Image (162K GIF file)]
In the medial septal and diagonal band nuclei, immunoreactivity for
Kv 1 and Kv 1 was present in the somatodendritic compartments of
magnocellular neurons. These neurons formed a continuous column of
cells extending through the medial septum and vertical and horizontal
limbs of the diagonal band and into the magnocellular neurons of the
nucleus basalis of Meynert. This pattern of Kv 1 and Kv 2
immunoreactivity was virtually identical to the distribution of Kv 1
and Kv 2 mRNA and is very similar to the distribution and
characteristic morphology of basal forebrain cholinergic neurons
(Mesulam et al., 1983 ).
Thalamus
Many cells within various thalamic nuclei were immunoreactive for
Kv 1 and Kv 2. The distribution of labeled cells corresponded
closely to the pattern of expression Kv 1 and Kv 2 mRNA. In
virtually all of these cells, a large proportion of the
immunoreactivity was concentrated within the somatic and dendritic
cytoplasm, suggesting that this staining is associated with the
-subunit polypeptides not yet transported to a distinct plasma
membrane domain.
Cerebellum
In the cerebellum, immunoreactivity for Kv 1 and Kv 2 was
concentrated within the cell bodies and dendrites of Purkinje cells and
was distributed diffusely and with moderate intensity throughout the
molecular layer (Fig. 7B,D). Immunoreactivity for
Kv 2 also was present in the axon terminals of basket cells. These
basket-cell terminals form a characteristic plexus surrounding the
initial segment of Purkinje cell axons and have been shown previously
to contain intense immunoreactivity for Kv1.1 and Kv1.2 subunits
(McNamara et al., 1993 ; Wang et al., 1993 , 1994 ; Rhodes et al., 1995 ;
Shi et al., 1996 ). Numerous fine-caliber axons within the granule cell
layer also contained immunoreactivity for Kv 1 and Kv 2, as did
large neurons within the deep cerebellar nuclei. The axons in the
granule cell layer appeared to originate from Purkinje cells and
frequently appeared to emerge from the core of labeling of the
basket-cell terminal plexus. Large-caliber myelinated axons in the
cerebellar white matter also contained intense immunoreactivity for
Kv 1 and Kv 2. As described above, this immunoreactivity was
strikingly discontinuous, with intense staining in patches juxtaposed
to nodes of Ranvier (Shi et al., 1996 ).
Midbrain and brainstem
Large motor and sensory neurons within structures such as
the red nucleus and all cranial nerve sensory and motor nuclei
contained moderate to intense immunoreactivity for Kv 1 and Kv 2
(Fig. 6A,C). In addition, neurons within the
substantia nigra pars reticulata and in the deep layers of the superior
colliculus were immunoreactive for these two -subunit polypeptides.
Large neurons within the midbrain and pontine reticular formation and
inferior olivary complex were moderately to intensely labeled by both
anti- -subunit antibodies, as were axons within midbrain and
brainstem white matter pathways and cranial nerve efferents.
DISCUSSION
Molecular, immunological, and neuroanatomical techniques were used
to examine the expression, distribution, and co-association of two
voltage-gated K+ channel subunits in adult
rat brain. Although the relative density of Kv 1 and Kv 2
expression and immunoreactivity differs considerably across brain
regions, the expression of these two subunits shows substantial
overlap, and in many cell populations the respective mRNAs and
polypeptides probably co-localize. The riboprobes used in the present
study reacted with single bands by Northern and Southern analysis, and
their specificity is supported by the observation that two independent
riboprobes targeted to nonoverlapping sequences of the target mRNA gave
identical hybridization patterns. Moreover, the pattern of
immunoreactivity revealed by Kv 1- and Kv 2-specific antibodies is
consistent with localization of the respective polypeptides to the cell
bodies, dendrites, or terminals of cells expressing the corresponding
mRNA. Antibodies raised against unique N-terminal sequences of Kv 1
and Kv 2 reacted with 44 kDa and 38 kDa polypeptides, respectively,
in membranes prepared from rat brain and transfected COS cells; in
brain, the 38 kDa Kv 2 polypeptide is far more abundant. On the basis
of reciprocal co-immunoprecipitation experiments, it appears that
almost all channel complexes containing Kv 1 also contain Kv 2.
Using subtype-specific anti- -subunit antibodies, we unambiguously
identified the Kv 1 and Kv 2 polypeptides in rat brain. We based
this identification on their reaction with antibodies made to unique
regions of the deduced amino acid sequence and their co-migration on
SDS gels with the recombinant protein expressed in transfected cells.
Together, these results indicate that in rat brain, Kv 1 is a
relatively low-abundance polypeptide of Mr = 44 kDa, whereas Kv 2 is an abundant polypeptide of
Mr = 38 kDa. Subsequent analyses of the
Mr = 44 kDa Kv 1 and
Mr = 38 kDa Kv 2 polypeptide pools in rat
brain membranes using a polyclonal antibody raised against a C-terminal
peptide conserved in both subunits (``pan- '' antibody) (Rhodes
et al., 1995 ) reveal a striking difference in the relative abundance of
these two subunits. Quantitative analysis of immunoblots performed
using the pan- -subunit antibody, which recognizes both Kv 1 and
Kv 2, shows that Kv 2 is ~50-fold more abundant than Kv 1 in
rat brain membranes, supporting the model we initially proposed (Rhodes
et al., 1995 ) that Kv 2 was by far the more abundant subunit
subtype in brain. In addition, most Kv 1 appears to be present in
complexes that also contain Kv 2, as evidenced by the fact that
Kv 1-containing complexes are co-immunoprecipitated using a
Kv 2-specific antibody. A small portion of the total Kv 2 pool in
brain is present in these complexes, as evidenced by the small amount
of Kv 2 in immunoprecipitations performed using the anti-Kv 1
antibody, thus most of the Kv 2 in brain appears to exist in
complexes lacking Kv 1. Conversely, it appears that the small amount
of Kv 1 present in brain exists in complexes containing Kv 2; very
few ``pure'' Kv 1 complexes are present.
Comparison of immunohistochemical staining patterns observed in the
present study with those obtained using the pan- antibody (Rhodes et
al., 1995 ) suggests that the immunoreactivity for Kv 2 recapitulates
virtually the entire pattern and extent of immunoreactivity observed
using the pan- antibody. If we assume that pan- staining
represents the total -subunit pool associated with Shaker
subunits, then we can assign Kv 2 as the major component of this
pool. In addition, we can assign Kv 1 as a comparatively minor
subcomponent, found predominantly in channel complexes that also
contain Kv 2 (Fig. 8). On the basis of this analysis,
we also can speculate that in brain, the distribution of other
-subunit isoforms containing this conserved C-terminal epitope
(England et al., 1995a ,b; Heinemann et al., 1995 ; Majumder et al.,
1995 ; Morales et al., 1995 ) will show considerable overlap with that
observed using the pan- and Kv 2-specific antibodies, and that
these other subunits will be present in rat brain
K+ channel complexes in association with
Kv 2.
Fig. 8.
Hypothetical model of -subunit associations in
rat brain. The total rat brain -subunit pool contains at least three
-subunit isoforms, designated Kv 1, Kv 2,
and Kv X in this Venn diagram. Immunoreactivity observed
using Kv 2-specific antibodies recapitulates virtually the entire
pattern and extent of immunoreactivity revealed using the pan-
antibody (Rhodes et al., 1995 ), suggesting that Kv 2 is present in
virtually all subunit-containing K+ channel
complexes. In contrast, immunoreactivity for Kv 1 is present in a
small proportion of pan- /Kv 2-immunoreactive structures. Because
the C-terminal epitope contained within the pan- antibody is present
in all cloned Kv subunits, it is likely that these -subunit
isoforms (designated Kv X) also will associate with a
subset of the total brain -subunit-containing complexes, i.e., in
complexes that also contain Kv 2.
[View Larger Version of this Image (20K GIF file)]
The pattern of Kv 1 expression reported here is virtually identical
to that reported for Kv 1 mRNA by Rettig et al. (1994) . Their data
and ours indicated that Kv 1 is highly expressed in the cortical
interneurons; basal ganglia; limbic cortical regions such as the
hippocampus, posterior cingulate, and entorhinal cortex; and brainstem
and cerebellum. In the majority of regions, immunoreactivity for Kv 1
is concentrated at the terminals of cells expressing Kv 1 mRNA. The
very high levels of Kv 1 expression in the caudate putamen
corresponded well to the high density of Kv 1 immunoreactivity in
terminal fields in the globus pallidus and substantia nigra and,
similarly, the high levels of Kv 1 expression in entorhinal cortex
correspond to a band of Kv 1 immunoreactivity in the molecular layer
of the dentate gyrus (data not shown). One clear exception to this
relationship is that numerous cortical and hippocampal interneurons
contain high levels of Kv 1 mRNA and also contain a high density of
Kv 1 immunoreactivity at their somata and proximal dendrites.
Overall, the pattern of Kv 1 expression corresponds closely to
that observed for Kv1.4 (Sheng et al., 1992 ) and, to a lesser extent,
Kv1.1 (Wang et al., 1994 ). In agreement, the high levels of Kv 1
immunoreactivity in the globus pallidus and pars reticulata of the
substantia nigra correspond closely to the patterns reported for Kv1.1
and Kv1.4 in these structures (Sheng et al., 1992 ; Wang et al., 1994 ).
Similarly, the high levels of Kv 1 immunoreactivity in cortical
interneurons corresponds closely to the patterns of expression and
immunoreactivity for Kv1.1, Kv1.2, and Kv1.6 subunits in these
cells (Wang et al., 1994 ) (M. Monaghan, N. Barrezueta, J. Trimmer, K. Rhodes, unpublished observations). This observation suggests that
Kv1.1, Kv1.2, Kv1.6, Kv 1, and perhaps Kv 2 may co-localize and
co-assemble in these cells. In view of the high spontaneous firing
rates and short-duration action potentials reported for cortical
(hippocampal) interneurons (Williams et al., 1994 ), it is tempting to
speculate that the high levels of Kv 1 expression and its subsequent
effects on associated subunits (Rettig et al., 1994 ) in these cells
are related to an intrinsic requirement for rapidly inactivating
channels.
Although Rettig et al. (1994) did not examine Kv 2 expression in
their study, the data reported here indicate that Kv 2 also is widely
expressed in rat brain. Cohen and his colleagues (Arai et al., 1992 ;
Cohen et al., 1992 ) have characterized the expression of a gene, F5
(Sabath et al., 1990 ), that is highly expressed in activated T
lymphocytes and brain. The recent submission of the F5 sequence to the
Genbank database identified F5 as the mouse homolog of Kv 2. The
pattern of F5 mRNA expression in brain (Arai et al., 1992 ; Cohen et
al., 1992 ) is qualitatively similar to that reported here for Kv 2,
but is described more accurately as a composite of Kv 1 and Kv 2
mRNA expression. This may be attributable to the probe that was used
for hybridization, which was derived from a region, which in rat, is
highly conserved between Kv 1 and Kv 2 (80% identity at the
nucleotide level).
Immunoreactivity for Kv 2 is concentrated in the juxtaparanodal
regions of myelinated axons and in terminal fields of cells expressing
Kv 2 mRNA. This is clearly evident in the cerebellar cortex, where
Kv 2 mRNA is expressed in basket cells and Kv 2 immunoreactivity
concentrated in the basket-cell terminal plexus, and in the
hippocampus, where Kv 2 mRNA is expressed in layer II cells in
entorhinal cortex and Kv 2 immunoreactivity is present in the
molecular layer of the dentate gyrus. However, there also are clear
examples of Kv 2 immunoreactivity in somatic and dendritic domains.
For example, in cortical and hippocampal pyramidal cells, Kv 2
immunoreactivity is concentrated in the cell body and throughout the
apical dendritic tree, and in cerebellar Purkinje cells, Kv 2
immunoreactivity is concentrated in somatic and dendritic domains.
In general, the pattern of expression and immunoreactivity for Kv 2
is best approximated by a composite of that reported for the Kv1.1 and
Kv1.2 subunits (Sheng et al., 1994 ; Wang et al., 1994 ; Rhodes et
al., 1995 ). In cerebellar basket-cell terminals, the pattern of Kv 2
immunoreactivity corresponds precisely to that observed for Kv1.1 and
Kv1.2 (McNamara et al., 1993 ; Wang et al., 1993 , 1994 ; Sheng et al.,
1994 ; Rhodes et al., 1995 ; Shi et al., 1996 ), indicating that Kv 2 is
likely to be associated with Kv1.1 and Kv1.2 in these complexes.
Similarly, in the juxtaparanodal membrane of myelinated axons, the
pattern of Kv 2 immunoreactivity is identical to that observed for
Kv1.1 and Kv1.2 (Wang et al., 1993 , 1994 ; Sheng et al., 1994 ; Shi et
al., 1996 ). In other regions, such as the somatodendritic membranes of
cortical pyramidal cells and the cell bodies of midbrain and brainstem
motor neurons, the pattern of Kv 2 immunoreactivity also corresponds
closely to Kv1.1 and Kv1.2. However, in other regions, such as the
apical dendritic trees of cortical and hippocampal pyramidal cells, the
pattern of Kv 2 immunoreactivity is matched by that for Kv1.6 (K. Rhodes, M. Monaghan, J. Trimmer, unpublished observations) and Kv4.2
(Sheng et al., 1992 ), but not by any of the other Kv1 family subunits. Because Kv 2 (and Kv 1) can associate with all Kv1 subunits, as well as Kv4.2, in heterologous expression systems
(Nakahira et al., 1996 ), in pyramidal cell dendrites, Kv 2 may be
present in channel complexes containing Kv1.6 or Kv4.2. However, this
association remains to be confirmed by reciprocal
co-immunoprecipitation studies.
The results of the present study indicate that subunits are
fundamental components of voltage-gated K+
channels in mammalian brain. Their widespread expression and tight
association with subunits suggests that they play a fundamental
role in the function of native channels (Parcej and Dolly, 1989 , 1992;
Trimmer, 1991 ; Scott et al., 1994a ,b; Rhodes et al., 1995 ; Shi et al.,
1996 ). As both Kv 1 and Kv 2 are found in both presynaptic (axons
and terminals) and postsynaptic (soma and dendrites) plasma membrane
domains, it may be assumed that they in themselves do not effectively
target K+ channels to specific subcellular
compartments (Sheng et al., 1992 , 1994 ). Some subunits, including
Kv 1, do exert dramatic effects on the electrophysiological
properties of expressed channels (Rettig et al., 1994 ; England et al.,
1995a ,b; Majumder et al., 1995 ; Morales et al., 1995 ). However, Kv 2,
the major subunit in brain, does not, raising questions as to its
precise function. We reported recently that Kv 2 exerts
chaperone-like effects on the Kv1.2 subunit, promoting its
efficient glycosylation, surface expression, and stability in the
plasma membrane (Shi et al., 1996 ). Similar effects are mediated by
Kv 1 (Shi et al., 1996 ). Interestingly, mutations in a
Drosophila subunit result in a reduction in the surface
density of K+ channel complexes (Chouinard et
al., 1995 ), supporting the contention that the effects of subunits
on the biosynthetic maturation and stability of subunits is a
fundamental role. Further definition of the sites where subunits
co-localize and co-associate with individual subunits will further
define the role of Kv 1 and Kv 2 in determining the properties of
K+ channel complexes in mammalian brain.
FOOTNOTES
Received Jan. 18, 1996; revised May 9, 1996; accepted May 21, 1996.
This work was supported by Wyeth-Ayerst Research and the Center for
Biotechnology at Stony Brook, and funded by the New York State Science
and Technology Foundation and by National Institutes of Health Grant
NS34383 (J.S.T.). This work was done during the tenure of an
Established Investigatorship from the American Heart Association
(J.S.T.). We thank Drs. James E. Barrett and John A. Moyer for
critically reviewing this manuscript.
Correspondence should be addressed to Dr. James S. Trimmer, Department
of Biochemistry and Cell Biology, State University of New York, Stony
Brook, NY 11794-5215.
REFERENCES
-
Arai M,
Prystowsky MB,
Cohen JA
(1992)
Expression of the
T-lymphocyte activation gene, F5, by mature neurons.
J Neurosci Res
33:527-537 .
[Web of Science][Medline]
-
Chouinard SW,
Wilson GF,
Schliomgen AK,
Ganetsky B
(1995)
A
potassium channel
subunit related to the aldo-keto reductase
superfamily is encoded by the Drosophila hyperkinetic locus.
Proc Natl Acad Sci USA
92:6763-6767 .
[Abstract/Free Full Text]
-
Cohen JA,
Arai M,
Luning Prak E,
Brooks SA,
Young LH,
Prystowsky MB
(1992)
Characterization of a novel mRNA expressed by
neurons in mature brain.
J Neurosci Res
31:273-284 .
[Web of Science][Medline]
-
England SK,
Uebele VN,
Kodali J,
Bennett PB,
Tamkun MM
(1995a)
A novel K+ channel
-subunit (hKv 1.3) is produced via alternative mRNA splicing.
J Biol Chem
270:28531-28534 .
[Abstract/Free Full Text]
-
England SK,
Uebele VN,
Shear H,
Kodali J,
Bennett PB,
Tamkun MM
(1995b)
Characterization of a voltage-gated
K+ channel
subunit expressed in human heart.
Proc Natl Acad Sci USA
92:6309-6313 .
[Abstract/Free Full Text]
-
Harlow E,
Lane D
(1988)
Antibodies: a laboratory manual.
.
-
Heinemann SH,
Rettig J,
Wunder F,
Pongs O
(1995)
Molecular
and functional characterization of a rat brain Kv
3 potassium channel
subunit.
FEBS Lett
377:383-389 .
[Web of Science][Medline]
-
Hille B
(1992)
Ionic channels of excitable membranes.
.
-
Isom LL,
De Jongh KS,
Catterall WA
(1994)
Auxiliary subunits
of voltage-gated ion channels.
Neuron
12:1183-1194 .
[Web of Science][Medline]
-
Jan LY,
Jan YN
(1990)
How might the diversity of potassium
channels be generated?
Trends Neurosci
13:415-419 .
[Web of Science][Medline]
-
Johnson DAG,
Sportsman JR,
Elder JH
(1984)
Improved technique
utilizing nonfat dry milk for analysis of proteins and nucleic acids
transferred to nitrocellulose.
Gene Anal Tech
1:3-8.
-
Maizel JV
(1971)
Polyacrylamide gel electrophoresis of viral
proteins.
Methods Virol
5:179-246.
-
Majumder K,
De Biasi M,
Wang Z,
Wible BA
(1995)
Molecular
cloning and functional expression of a novel potassium channel
-subunit from human atrium.
FEBS Lett
361:13-16 .
[Web of Science][Medline]
-
McCormack K,
McCormack T,
Tanouye M,
Rudy B,
Stühmer W
(1995)
Alternative splicing of the human Shaker
K+ channel
1 gene and functional expression of
a 2 gene product.
FEBS Lett
370:32-36 .
[Web of Science][Medline]
-
McNamara NM,
Muniz ZM,
Wilkin GP,
Dolly JO
(1993)
Prominent
location of a K+ channel containing the alpha
subunit Kv1.2 in the basket cell nerve terminals of rat cerebellum.
Neuroscience
57:1039-1045 .
[Web of Science][Medline]
-
Mesulam M-M,
Mufson EJ,
Wainer BH,
Levey AI
(1983)
Central
cholinergic pathways in the rat: an overview based on an alternative
nomenclature (Ch1-Ch6).
Neuroscience
10:1185-1201 .
[Web of Science][Medline]
-
Morales MJ,
Castellino RC,
Crews AL,
Rasmussen RL,
Strauss HC
(1995)
A novel
subunit increases the rate of
inactivation of specific voltage-gated potassium channel subunits.
J Biol Chem
270:6272-6277 .
[Abstract/Free Full Text]
-
Nakahira K,
Shi G,
Rhodes KJ,
Trimmer JS
(1996)
Selective
interaction of voltage-gated K+ channel
-subunits with -subunits.
J Biol Chem
271:7084-7089 .
[Abstract/Free Full Text]
-
Parcej DN,
Dolly JO
(1989)
Elegance persists in the
purification of K+ channels.
Biochem J
264:623-624 .
[Web of Science][Medline]
-
Parcej DN,
Scott VES,
Dolly JO
(1992)
Oligomeric properties of
-dendrotoxin-sensitive potassium channels purified from bovine
brain.
Biochemistry
31:11084-11088 .
[Medline]
-
Pongs O (1992) Molecular biology of voltage-dependent
potassium channels. Physiol Rev 72 [Suppl 4]:S69-S88.
-
Pongs O
(1995)
Regulation of the activity of voltage-gated
potassium channels by
subunits.
Semin Neurosci
7:137-146. -
Rettig J,
Heinemann SH,
Wunder F,
Lorra C,
Parcej DN,
Dolly JO,
Pongs O
(1994)
Inactivation properties of voltage-gated
K+ channels altered by presence of
-subunit.
Nature
369:289-294 .
[Medline]
-
Rhodes KJ,
Keilbaugh SA,
Barrezueta NX,
Lopez KL,
Trimmer JS
(1995)
Association and colocalization of
K+ channel
- and -subunit polypeptides in
rat brain.
J Neurosci
15:5630-5671.
-
Ruppersberg JP,
Schroter KH,
Sakmann B,
Stocker M,
Sewing S,
Pongs O
(1990)
Heteromultimeric channels formed by rat brain potassium-channel
protein.
Nature
345:535-537 .
[Medline]
-
Sabath DE,
Podolin PL,
Comber PG,
Prystowsky MB
(1990)
cDNA
cloning and characterization of interleukin 2-induced genes in a cloned
T helper lymphocyte.
J Biol Chem
265:12671-12678 .
[Abstract/Free Full Text]
-
Scott VE,
Muniz ZM,
Sewing S,
Lichtinghagen R,
Parcej DN,
Pongs O,
Dolly JO
(1994a)
Antibodies specific for distinct Kv subunits
unveil a hetero-oligomeric basis for subtypes of
-dendrotoxin-sensitive K+ channels in bovine
brain.
Biochemistry
33:1617-1623 .
[Medline]
-
Scott VE,
Rettig J,
Parcej DN,
Keen JN,
Findlay JB,
Pongs O,
Dolly JO
(1994b)
Primary structure of a
-subunit of
-dendrotoxin-sensitive K+ channels from bovine
brain.
Proc Natl Acad Sci USA
91:1637-1641 .
[Abstract/Free Full Text]
-
Sheng M,
Tsaur ML,
Jan YN,
Jan LY
(1992)
Subcellular
segregation of two A-type K+ channel proteins in
rat central neurons.
Neuron
9:271-284 .
[Web of Science][Medline]
-
Sheng M,
Liao YJ,
Jan YN,
Jan LY
(1993)
Presynaptic
A-current based on heteromultimeric K+ channels
detected in vivo.
Nature
365:72-75 .
[Medline]
-
Sheng M,
Tsaur ML,
Jan YN,
Jan LY
(1994)
Contrasting
subcellular localization of the Kv1.2 K+ channel
subunits in different neurons of rat brain.
J Neurosci
14:2408-2417 .
[Abstract]
-
Shi G,
Kleinklaus A,
Marrion N,
Trimmer JS
(1994)
Properties of Kv2.1
K+ channels expressed in transfected mammalian cells.
J Biol Chem
269:23204-23211 .
[Abstract/Free Full Text]
-
Shi G,
Nakahira K,
Hammond S,
Rhodes KJ,
Schechter LE,
Trimmer JS
(1996)
-subunits promote K+
channel surface expression through effects early in biosynthesis.
Neuron
16:843-852 .
[Web of Science][Medline]
-
Stühmer W,
Ruppersberg JP,
Schroter KH,
Sakmann B,
Stocker M,
Giese KP,
Perschke A,
Baumann A,
Pongs O
(1989)
Molecular
basis of functional diversity of voltage gated potassium channels in
mammalian brain.
EMBO J
8:3235-3244 .
[Web of Science][Medline]
-
Trimmer JS
(1991)
Immunological identification and
characterization of a delayed rectifier K+
channel in rat brain.
Proc Natl Acad Sci USA
88:10764-10768 .
[Abstract/Free Full Text]
-
Trimmer JS,
Trowbridge IS,
Vacquier VD
(1985)
Monoclonal antibody
to a membrane glycoprotein inhibits the acrosome reaction and
associated Ca2+and H+ fluxes of sea urgin
sperm.
Cell
40:697-703 .
[Web of Science][Medline]
-
Wang H,
Kunkel DD,
Martin TM,
Schwartzkroin PA,
Tempel BL
(1993)
Heteromultimeric K+ channels
in terminal and juxtaparanodal regions of neurons.
Nature
365:75-79 .
[Medline]
-
Wang H,
Kunkel DD,
Martin TM,
Schwartzkroin PA,
Tempel BL
(1994)
Localization of Kv1.1 and Kv1.2, two K channel
proteins, to synaptic terminals, somata, and dendrites in the mouse
brain.
J Neurosci
14:4588-4599 .
[Abstract]
-
Williams S,
Samulack DD,
Beaulieu C,
LaCaille JC
(1994)
Membrane properties and synaptic responses of
interneurons located near the stratum lacunosum-moleculare/radiatum
border of area CA1 in whole-cell recordings from rat hippocampal
slices.
J Neurophysiol
71:2217-2235 .
[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
R. H. Pineda, C. S. Knoeckel, A. D. Taylor, A. Estrada-Bernal, and A. B. Ribera
Kv1 Potassium Channel Complexes In Vivo Require Kv{beta}2 Subunits in Dorsal Spinal Neurons
J Neurophysiol,
October 1, 2008;
100(4):
2125 - 2136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Vacher, D. P. Mohapatra, and J. S. Trimmer
Localization and Targeting of Voltage-Dependent Ion Channels in Mammalian Central Neurons
Physiol Rev,
October 1, 2008;
88(4):
1407 - 1447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Rhodes and J. S. Trimmer
Antibody-based Validation of CNS Ion Channel Drug Targets
J. Gen. Physiol.,
May 1, 2008;
131(5):
407 - 413.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Rhodes and J. S. Trimmer
Antibodies as Valuable Neuroscience Research Tools versus Reagents of Mass Distraction
J. Neurosci.,
August 2, 2006;
26(31):
8017 - 8020.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M Schott
Limbic encephalitis: a clinician's guide
Practical Neurology,
June 1, 2006;
6(3):
143 - 153.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E McKay and R. W Turner
Physiological and morphological development of the rat cerebellar Purkinje cell
J. Physiol.,
September 15, 2005;
567(3):
829 - 850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. McKay, M. L. Molineux, W. H. Mehaffey, and R. W. Turner
Kv1 K+ Channels Control Purkinje Cell Output to Facilitate Postsynaptic Rebound Discharge in Deep Cerebellar Neurons
J. Neurosci.,
February 9, 2005;
25(6):
1481 - 1492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Rhodes, K. I. Carroll, M. A. Sung, L. C. Doliveira, M. M. Monaghan, S. L. Burke, B. W. Strassle, L. Buchwalder, M. Menegola, J. Cao, et al.
KChIPs and Kv4 {alpha} Subunits as Integral Components of A-Type Potassium Channels in Mammalian Brain
J. Neurosci.,
September 8, 2004;
24(36):
7903 - 7915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Birnbaum, A. W. Varga, L.-L. Yuan, A. E. Anderson, J. D. Sweatt, and L. A. Schrader
Structure and Function of Kv4-Family Transient Potassium Channels
Physiol Rev,
July 1, 2004;
84(3):
803 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vincent, C. Buckley, J. M. Schott, I. Baker, B.-K. Dewar, N. Detert, L. Clover, A. Parkinson, C. G. Bien, S. Omer, et al.
Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis
Brain,
March 1, 2004;
127(3):
701 - 712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Sokolova, A. Accardi, D. Gutierrez, A. Lau, M. Rigney, and N. Grigorieff
Conformational changes in the C terminus of Shaker K+ channel bound to the rat Kv{beta}2-subunit
PNAS,
October 28, 2003;
100(22):
12607 - 12612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sacco and F. Tempia
A-Type potassium currents active at subthreshold potentials in mouse cerebellar purkinje cells
J. Physiol.,
September 1, 2002;
543(2):
505 - 520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A Lazaroff, A. D Taylor, and A. B Ribera
In vivo analysis of Kv{beta}2 function in Xenopus embryonic myocytes
J. Physiol.,
June 15, 2002;
541(3):
673 - 683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. McCormack, J. X. Connor, L. Zhou, L. L. Ho, B. Ganetzky, S.-Y. Chiu, and A. Messing
Genetic Analysis of the Mammalian K+ Channel beta Subunit Kvbeta 2 (Kcnab2)
J. Biol. Chem.,
April 5, 2002;
277(15):
13219 - 13228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Campomanes, K. I. Carroll, L. N. Manganas, M. E. Hershberger, B. Gong, D. E. Antonucci, K. J. Rhodes, and J. S. Trimmer
Kvbeta Subunit Oxidoreductase Activity and Kv1 Potassium Channel Trafficking
J. Biol. Chem.,
March 1, 2002;
277(10):
8298 - 8305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Holmqvist, J. Cao, R. Hernandez-Pineda, M. D. Jacobson, K. I. Carroll, M. A. Sung, M. Betty, P. Ge, K. J. Gilbride, M. E. Brown, et al.
Elimination of fast inactivation in Kv4 A-type potassium channels by an auxiliary subunit domain
PNAS,
January 22, 2002;
99(2):
1035 - 1040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Rasband, E. W. Park, T. W. Vanderah, J. Lai, F. Porreca, and J. S. Trimmer
Distinct potassium channels on pain-sensing neurons
PNAS,
November 6, 2001;
98(23):
13373 - 13378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Bains, M. J. Follwell, K. J. Latchford, J. W. Anderson, and A. V. Ferguson
Slowly Inactivating Potassium Conductance (ID): A Potential Target for Stroke Therapy
Stroke,
November 1, 2001;
32(11):
2624 - 2634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Monaghan, J. S. Trimmer, and K. J. Rhodes
Experimental Localization of Kv1 Family Voltage-Gated K+ Channel {alpha} and {beta} Subunits in Rat Hippocampal Formation
J. Neurosci.,
August 15, 2001;
21(16):
5973 - 5983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Saito and T. Isa
Voltage-gated transient outward currents in neurons with different firing patterns in rat superior colliculus
J. Physiol.,
October 1, 2000;
528(1):
91 - 105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Korngreen and B. Sakmann
Voltage-gated K+ channels in layer 5 neocortical pyramidal neurones from young rats: subtypes and gradients
J. Physiol.,
June 15, 2000;
525(3):
621 - 639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Southan and B. Robertson
Electrophysiological Characterization of Voltage-Gated K+ Currents in Cerebellar Basket and Purkinje Cells: Kv1 and Kv3 Channel Subfamilies Are Present in Basket Cell Nerve Terminals
J. Neurosci.,
January 1, 2000;
20(1):
114 - 122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Lazaroff, A. D. Hofmann, and A. B. Ribera
Xenopus Embryonic Spinal Neurons Express Potassium Channel Kvbeta Subunits
J. Neurosci.,
December 15, 1999;
19(24):
10706 - 10715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Zhang, A. Messing, and S. Y. Chiu
Specific Alteration of Spontaneous GABAergic Inhibition in Cerebellar Purkinje Cells in Mice Lacking the Potassium Channel Kv1.1
J. Neurosci.,
April 15, 1999;
19(8):
2852 - 2864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Sutherland, S. H. Williams, R. Abedi, P. A. Overbeek, P. J. Pfaffinger, and J. L. Noebels
Overexpression of a Shaker-type potassium channel in mammalian central nervous system dysregulates native potassium channel gene expression
PNAS,
March 2, 1999;
96(5):
2451 - 2455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Vabnick, J. S. Trimmer, T. L. Schwarz, S. R. Levinson, D. Risal, and P. Shrager
Dynamic Potassium Channel Distributions during Axonal Development Prevent Aberrant Firing Patterns
J. Neurosci.,
January 15, 1999;
19(2):
747 - 758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Leicher, R. Bahring, D. Isbrandt, and O. Pongs
Coexpression of the KCNA3B Gene Product with Kv1.5 Leads to a Novel A-type Potassium Channel
J. Biol. Chem.,
December 25, 1998;
273(52):
35095 - 35101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Giese, J. F. Storm, D. Reuter, N. B. Fedorov, L.-R. Shao, T. Leicher, O. Pongs, and A. J. Silva
Reduced K+ Channel Inactivation, Spike Broadening, and After-Hyperpolarization in Kvbeta 1.1-Deficient Mice with Impaired Learning
Learn. Mem.,
September 1, 1998;
5(4):
257 - 273.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. P. Southan and B. Robertson
Patch-Clamp Recordings from Cerebellar Basket Cell Bodies and Their Presynaptic Terminals Reveal an Asymmetric Distribution of Voltage-Gated Potassium Channels
J. Neurosci.,
February 1, 1998;
18(3):
948 - 955.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Rasband, J. S. Trimmer, T. L. Schwarz, S. R. Levinson, M. H. Ellisman, M. Schachner, and P. Shrager
Potassium Channel Distribution, Clustering, and Function in Remyelinating Rat Axons
J. Neurosci.,
January 1, 1998;
18(1):
36 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Accili, J. Kiehn, B. A. Wible, and A. M. Brown
Interactions among Inactivating and Noninactivating Kvbeta Subunits, and Kvalpha 1.2, Produce Potassium Currents with Intermediate Inactivation
J. Biol. Chem.,
November 7, 1997;
272(45):
28232 - 28236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Rhodes, B. W. Strassle, M. M. Monaghan, Z. Bekele-Arcuri, M. F. Matos, and J. S. Trimmer
Association and Colocalization of the Kvbeta 1 and Kvbeta 2 beta -Subunits with Kv1 alpha -Subunits in Mammalian Brain K+ Channel Complexes
J. Neurosci.,
November 1, 1997;
17(21):
8246 - 8258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Baro, R. M. Levini, M. T. Kim, A. R. Willms, C. C. Lanning, H. E. Rodriguez, and R. M. Harris-Warrick
Quantitative Single-Cell-Reverse Transcription-PCR Demonstrates That A-Current Magnitude Varies as a Linear Function of shal Gene Expression in Identified Stomatogastric Neurons
J. Neurosci.,
September 1, 1997;
17(17):
6597 - 6610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xu and M. Li
Kvbeta 2 Inhibits the Kvbeta 1-mediated Inactivation of K+ Channels in Transfected Mammalian Cells
J. Biol. Chem.,
May 2, 1997;
272(18):
11728 - 11735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. N. Manganas and J. S. Trimmer
Subunit Composition Determines Kv1 Potassium Channel Surface Expression
J. Biol. Chem.,
September 15, 2000;
275(38):
29685 - 29693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Firulli, D. B. Hadzic, J. R. McDaid, and A. B. Firulli
The Basic Helix-Loop-Helix Transcription factors dHAND and eHAND Exhibit Dimerization Characteristics That Suggest Complex Regulation of Function
J. Biol. Chem.,
October 20, 2000;
275(43):
33567 - 33573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Kajkowski, C. F. Lo, X. Ning, S. Walker, H. J. Sofia, W. Wang, W. Edris, P. Chanda, E. Wagner, S. Vile, et al.
beta -Amyloid Peptide-induced Apoptosis Regulated by a Novel Protein Containing a G Protein Activation Module
J. Biol. Chem.,
May 25, 2001;
276(22):
18748 - 18756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. N. Manganas, S. Akhtar, D. E. Antonucci, C. R. Campomanes, J. O. Dolly, and J. S. Trimmer
Episodic Ataxia Type-1 Mutations in the Kv1.1 Potassium Channel Display Distinct Folding and Intracellular Trafficking Properties
J. Biol. Chem.,
December 21, 2001;
276(52):
49427 - 49434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Ahlijanian, N. X. Barrezueta, R. D. Williams, A. Jakowski, K. P. Kowsz, S. McCarthy, T. Coskran, A. Carlo, P. A. Seymour, J. E. Burkhardt, et al.
Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
PNAS,
March 14, 2000;
97(6):
2910 - 2915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. N. Manganas, Q. Wang, R. H. Scannevin, D. E. Antonucci, K. J. Rhodes, and J. S. Trimmer
Identification of a trafficking determinant localized to the Kv1 potassium channel pore
PNAS,
November 20, 2001;
98(24):
14055 - 14059.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|